1. Home
  2. AXSM vs HASI Comparison

AXSM vs HASI Comparison

Compare AXSM & HASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • HASI
  • Stock Information
  • Founded
  • AXSM 2012
  • HASI 1981
  • Country
  • AXSM United States
  • HASI United States
  • Employees
  • AXSM N/A
  • HASI N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • HASI Real Estate Investment Trusts
  • Sector
  • AXSM Health Care
  • HASI Real Estate
  • Exchange
  • AXSM Nasdaq
  • HASI Nasdaq
  • Market Cap
  • AXSM 4.2B
  • HASI 3.2B
  • IPO Year
  • AXSM 2015
  • HASI 2013
  • Fundamental
  • Price
  • AXSM $84.60
  • HASI $27.50
  • Analyst Decision
  • AXSM Strong Buy
  • HASI Strong Buy
  • Analyst Count
  • AXSM 14
  • HASI 12
  • Target Price
  • AXSM $125.54
  • HASI $39.67
  • AVG Volume (30 Days)
  • AXSM 893.5K
  • HASI 1.1M
  • Earning Date
  • AXSM 02-18-2025
  • HASI 02-13-2025
  • Dividend Yield
  • AXSM N/A
  • HASI 5.98%
  • EPS Growth
  • AXSM N/A
  • HASI 358.98
  • EPS
  • AXSM N/A
  • HASI 1.82
  • Revenue
  • AXSM $338,457,000.00
  • HASI $139,077,000.00
  • Revenue This Year
  • AXSM $44.77
  • HASI N/A
  • Revenue Next Year
  • AXSM $67.70
  • HASI $7.51
  • P/E Ratio
  • AXSM N/A
  • HASI $15.22
  • Revenue Growth
  • AXSM 51.47
  • HASI 14.37
  • 52 Week Low
  • AXSM $64.11
  • HASI $21.77
  • 52 Week High
  • AXSM $105.00
  • HASI $36.56
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 43.66
  • HASI 45.28
  • Support Level
  • AXSM $79.19
  • HASI $26.07
  • Resistance Level
  • AXSM $87.53
  • HASI $27.90
  • Average True Range (ATR)
  • AXSM 4.37
  • HASI 0.73
  • MACD
  • AXSM -0.02
  • HASI 0.10
  • Stochastic Oscillator
  • AXSM 61.27
  • HASI 69.42

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About HASI Hannon Armstrong Sustainable Infrastructure Capital Inc.

HA Sustainable Infrastructure Capital Inc is a climate investment firm that actively partners with clients to deploy real assets that facilitate the energy transition. It invests in behind-the-meter (BTM) building or facility-specific distributed energy projects which reduce energy usage or cost, Grid-connected (GC) renewable energy projects that deploy cleaner energy sources, such as solar, solar-plus-storage, and onshore wind, to generate power production and Fuels, Transport & Nature projects.

Share on Social Networks: